Placebo-adjusted mean weight loss of 16.3% (39 lbs) at 180 mg and 16.0% (37 lbs) at 240 mg at 44 weeks with no evidence of weight loss plateau in ACCESS II, demonstrating highest efficacy among oral ...
Structure Therapeutics is developing a daily GLP-1 receptor pill called aleniglipron. Structure Therapeutics' stock soared toward an 18-month high in early Monday trading, after mid-stage data for its ...
Placebo-adjusted mean weight loss of 11.3% (27.3 lbs) with 120 mg dose in the 36-week Phase 2b ACCESS study with a 10.4% adverse event-related treatment discontinuation Placebo-adjusted mean weight ...
In this tutorial, you’ll learn how to build a flying couch in Minecraft that actually moves. The design focuses on mobility and appearance, creating a fun and unique flying structure that functions ...
Spending time as wee hackers perusing the family atlas taught us an appreciation for a good map, and [Billy Roberts], a cartographer at NREL, has served up a doozy with a map of the data center ...
Unlock the power of your data with an effective data governance framework for security, compliance, and decision-making. Data governance frameworks are structured approaches to managing and utilizing ...
Structure Therapeutics' stock has declined over 40% since last year, but its differentiated technology platform and promising drug pipeline still support a "Buy" rating. Structure's lead candidate, ...
Vibhas is a Software Development Manager at Amazon with over 12 years of industry experience in large scale distributed systems, databases and cloud native applications. Vibhas is a Software ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results